Former NXT Capital Execs Join Golub Late Stage Lending Group
Golub Capital added Peter Fair and Robert Sverbilov as part of the expansion of its Late Stage Lending platform. Fair and Sverbilov both joined from NXT Capital Venture Finance.
Golub Capital added Peter Fair and Robert Sverbilov as part of the expansion of its Late Stage Lending platform. Fair and Sverbilov both joined from NXT Capital Venture Finance.
Golub Capital announced Hyun Chang and Michael Meagher have joined as managing directors. Chang joined from J.P. Morgan Securities and Meagher joined from Deutsche Bank Securities.
Golub Capital acted as administrative agent and joint lead arranger in providing an $85 million first lien term loan and $20 million second lien term loan to support the acquisition of R.G. Barry Corporation by Mill Road Capital.
Golub Capital said as sole lead arranger, it provided a senior credit facility to support the acquisition of Tate’s Bank Shop by private equity firm The Riverside Company.
Golub Capital announced that as sole bookrunner, sole lead arranger and administrative agent, it provided a GOLD financing to support the acquisition of BECO Holding Company by Behrman Capital.
Golub Capital announced that as administrative agent and sole bookrunner it provided a $55 million GOLD financing to support the refinancing of Pyramid Healthcare by Clearview Capital.
Golub Capital announced that as administrative agent and sole bookrunner it provided a $55 million GOLD financing to support the refinancing of Pyramid Healthcare by Clearview Capital.
Golub Capital announced that as sole bookrunner and administrative agent, it provided a $165 million GOLD financing to support the acquisition of Marshall Retail Group by Brentwood Associates.
Golub Capital announced that as sole bookrunner and administrative agent, it provided a $165 million GOLD financing to support the acquisition of Marshall Retail Group by Brentwood Associates.
Golub Capital acted as sole lead arranger and administrative agent in the acquisition of California Cryobank by Longitude Venture Partners and NovaQuest Pharma Opportunities Fund.